MedTrace Logo

Effects of Osteopathic Treatment on Pulmonary Function After Coronary Artery Bypass Graft Surgery

NCT01714791 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2018-03-05

No results posted yet for this study

Summary

The purpose of this study is to determine the short and long term effects of osteopathic treatment on pulmonary function, pain and quality of life in patients after coronary artery bypass graft (CABG) surgery. The study is a randomized controlled trial.

Conditions

  • Mechanical Complication of Coronary Artery Bypass Graft
  • Respiratory Depression
  • Pain
  • Quality of Life

Interventions

OTHER

Usual care

Patients exercise at a heart rate corresponding to 65% of baseline Vo2peak. Each exercise training session takes 40-60 minutes. Exercise time is apportioned as follows: 42% on the treadmill, 33% on the circle ergometer and 25% on the arm cranking device. All patients exercise under close supervision 3 days per week for a total duration of 12 weeks.

OTHER

Osteopathic treatment

Patients receive 4 osteopathic treatments (OT). OT is performed in week 4, 5, 8 and 12 postoperative. Depending on what is found in the patient, treatments consist mostly of one or more of the following approaches: * Structural High Velocity Low Amplitude-techniques. * Muscle Energy Techniques. * General osteopathic mobilisations. * Functional techniques (Sutherland-, Jones-techniques,…) including inhibition techniques. * Fascia techniques. * Soft tissue- and connective tissue techniques. * Neurovisceral and neurolymphatic reflex techniques. * Fluidal techniques (lymphatic manipulative techniques,...). * Visceral manipulations. * Neurocranial and viscerocranial techniques.

Sponsors & Collaborators

  • Hartcentrum Hasselt

    lead OTHER

Principal Investigators

  • Gert Roncada, DO, MSc · Heart Centre Hasselt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01714791 on ClinicalTrials.gov